bxp inc. - BXP
BXP
Close Chg Chg %
63.15 1.57 2.49%
Closed Market
64.72
+1.57 (2.49%)
Volume: 3.46M
Last Updated:
Feb 6, 2026, 3:59 PM EDT
Company Overview: bxp inc. - BXP
BXP Key Data
| Open $63.64 | Day Range 62.87 - 64.83 |
| 52 Week Range 54.22 - 79.33 | Market Cap $10.10B |
| Shares Outstanding 158.47M | Public Float 157.27M |
| Beta 1.02 | Rev. Per Employee N/A |
| P/E Ratio 36.26 | EPS $1.75 |
| Yield 531.90% | Dividend $0.70 |
| EX-DIVIDEND DATE Dec 31, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.11M |
BXP Performance
| 1 Week | 0.08% | ||
| 1 Month | -4.80% | ||
| 3 Months | -10.56% | ||
| 1 Year | -11.03% | ||
| 5 Years | -29.74% |
BXP Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
23
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 76.722 | |
| Number of Ratings | 23 | Current Quarters Estimate | 0.288 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 1.748 | |
| Last Quarter’s Earnings | 1.56 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.74 | Next Fiscal Year Estimate | 1.956 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 5 | 7 | 7 |
| Mean Estimate | 0.29 | 0.40 | 1.75 | 1.96 |
| High Estimates | 0.42 | 0.57 | 2.30 | 2.53 |
| Low Estimate | 0.06 | 0.12 | 0.91 | 1.36 |
| Coefficient of Variance | 48.53 | 42.81 | 26.61 | 24.82 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 10 | 10 | 9 |
| OVERWEIGHT | 2 | 2 | 1 |
| HOLD | 11 | 11 | 14 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Bxp Inc. - BXP
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Bxp Inc. - BXP
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jan 28, 2026 | Hilary Spann Executive Vice President | 6,269 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.11 per share | 420,712.59 |
| Jan 28, 2026 | Eric G. Kevorkian SVP, CLO and Secretary | 511 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.11 per share | 34,293.21 |
| Jan 28, 2026 | Michael E. LaBelle EVP and CFO | 7,971 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.11 per share | 534,933.81 |
| Nov 26, 2025 | Peter V. Otteni Executive Vice President | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $72.65 per share | 0.00 |
| Nov 18, 2025 | Peter V. Otteni Executive Vice President of GP | 49,274 | Conversion of derivative security | 0.00 |
| Nov 18, 2025 | Peter V. Otteni Executive Vice President of GP | N/A | Conversion of derivative security | 0.00 |
| Aug 8, 2025 | John J. Stroman Executive Vice President of GP | 51,351 | Conversion of derivative security | 0.00 |
| Aug 8, 2025 | John J. Stroman Executive Vice President of GP | N/A | Conversion of derivative security | 0.00 |
| Aug 8, 2025 | John J. Stroman Executive Vice President | 16,838 | Conversion of derivative security | 0.00 |
| Jul 2, 2025 | Derek Anthony West Director | 3,142 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 2, 2025 | William H Walton Director | 8,252 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 2, 2025 | Joel Irwin Klein Director | 21,136 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 2, 2025 | Mary E. Kipp Director | 6,401 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 2, 2025 | Julie G. Richardson Director | 162 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 2, 2025 | Matthew J. Lustig Director | 18,714 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 2, 2025 | Bruce W. Duncan Director | 11,192 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Apr 2, 2025 | Carol B. Einiger Director | 32,435 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 7, 2025 | Donna D. Garesche EVP, Chief HR Officer | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $67.87 per share | 0.00 |